المؤلفون: Imrie, H, Viswambharan, H, Sukumar, P, Abbas, A, Cubbon, RM, Yuldasheva, N, Gage, M, Smith, J, Galloway, S, Skromna, A, Rashid, ST, Futers, TS, Xuan, S, Gatenby, VK, Grant, PJ, Channon, KM, Beech, DJ, Wheatcroft, SB, Kearney, MT

المصدر: Diabetes. 61(9)

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::28e8d93af410d48a6b206ec118d37f82
http://ora.ox.ac.uk/objects/uuid:396eae77-dd2b-4b0a-b59d-95d6b2095146

المؤلفون: Palin V; Leeds Institute of Cardiovascular and Metabolic Medicine, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK., Drozd M; Leeds Institute of Cardiovascular and Metabolic Medicine, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK., Garland E; Leeds Institute of Cardiovascular and Metabolic Medicine, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK., Malik A; Leeds Institute of Cardiovascular and Metabolic Medicine, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK., Straw S; Leeds Institute of Cardiovascular and Metabolic Medicine, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK., McGinlay M; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Simms A; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Gatenby VK; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Sengupta A; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Levelt E; Leeds Institute of Cardiovascular and Metabolic Medicine, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK., Witte KK; Leeds Institute of Cardiovascular and Metabolic Medicine, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK.; Medical Clinic 1, University Hospital Aachen, RWTH, Aachen, Germany., Kearney MT; Leeds Institute of Cardiovascular and Metabolic Medicine, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK., Cubbon RM; Leeds Institute of Cardiovascular and Metabolic Medicine, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK.

المصدر: ESC heart failure [ESC Heart Fail] 2022 Oct; Vol. 9 (5), pp. 3298-3307. Date of Electronic Publication: 2022 Jul 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2055-5822 (Electronic) Linking ISSN: 20555822 NLM ISO Abbreviation: ESC Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Heart Failure*/drug therapy , Heart Failure*/epidemiology, Humans ; Angiotensin Receptor Antagonists/therapeutic use ; Stroke Volume/physiology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Aftercare ; Prevalence ; Ventricular Function, Left ; Patient Discharge ; Hospitalization ; Adrenergic beta-Antagonists/therapeutic use ; Risk Factors

المؤلفون: Viswambharan H; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Yuldasheva NY; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Imrie H; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Bridge K; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Haywood NJ; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Skromna A; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Hemmings KE; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Clark ER; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Gatenby VK; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Cordell P; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Simmons KJ; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Makava N; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Abudushalamu Y; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Endesh N; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Brown J; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Walker AMN; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Futers ST; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Porter KE; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Cubbon RM; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Naseem K; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Shah AM; British Heart Foundation Centre of Research Excellence, King's College London (A.M.S.)., Beech DJ; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Wheatcroft SB; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Kearney MT; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.)., Sukumar P; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

المصدر: Circulation research [Circ Res] 2021 Sep 17; Vol. 129 (7), pp. 720-734. Date of Electronic Publication: 2021 Aug 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0047103 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4571 (Electronic) Linking ISSN: 00097330 NLM ISO Abbreviation: Circ Res Subsets: MEDLINE

مواضيع طبية MeSH: Paracrine Communication*, Adipose Tissue/*metabolism , Diabetes Mellitus, Type 2/*metabolism , Endothelium, Vascular/*metabolism , Glucose/*metabolism , Muscle, Skeletal/*metabolism, Animals ; Cells, Cultured ; Humans ; Hydrogen Peroxide/metabolism ; Insulin/metabolism ; Insulin-Like Growth Factor I/metabolism ; Mice ; Mice, Inbred C57BL ; MicroRNAs/genetics ; MicroRNAs/metabolism ; NADPH Oxidase 4/genetics ; NADPH Oxidase 4/metabolism ; Receptor, IGF Type 1/genetics ; Receptor, IGF Type 1/metabolism

المؤلفون: Drozd M; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Relton SD; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Walker AMN; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Slater TA; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Gierula J; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Paton MF; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Lowry J; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Straw S; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Koshy A; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., McGinlay M; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Simms AD; Department of Cardiology, Leeds General Infirmary, Leeds, UK., Gatenby VK; Department of Cardiology, Leeds General Infirmary, Leeds, UK., Sapsford RJ; Department of Cardiology, Leeds General Infirmary, Leeds, UK., Witte KK; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Kearney MT; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Cubbon RM; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK r.cubbon@leeds.ac.uk.

المصدر: Heart (British Cardiac Society) [Heart] 2021 Sep; Vol. 107 (17), pp. 1417-1421. Date of Electronic Publication: 2020 Nov 05.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9602087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-201X (Electronic) Linking ISSN: 13556037 NLM ISO Abbreviation: Heart Subsets: MEDLINE

مواضيع طبية MeSH: Heart Failure, Systolic*/diagnosis , Heart Failure, Systolic*/mortality , Life Expectancy*, Diabetes Mellitus/*epidemiology , Lung Diseases/*epidemiology , Renal Insufficiency, Chronic/*epidemiology, Aged ; Comorbidity ; Female ; Humans ; Male ; Prognosis ; Sex Factors ; Survival Analysis ; United Kingdom/epidemiology

المؤلفون: Gatenby VK; Department of Diabetes and Cardiovascular Research, LIGHT Laboratories, University of Leeds, Clarendon Way, Leeds, LS2 9NL, UK. kategatenby@gmail.com, Imrie H, Kearney M

المصدر: Pflugers Archiv : European journal of physiology [Pflugers Arch] 2013 Aug; Vol. 465 (8), pp. 1065-74. Date of Electronic Publication: 2013 Jan 22.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 0154720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2013 (Electronic) Linking ISSN: 00316768 NLM ISO Abbreviation: Pflugers Arch Subsets: MEDLINE

مواضيع طبية MeSH: Endothelium/*metabolism , Insulin/*metabolism , Nitric Oxide/*metabolism , Receptor, IGF Type 1/*metabolism , Signal Transduction/*physiology, Animals ; Biological Availability ; Endothelial Cells/metabolism ; Endothelial Cells/physiology ; Endothelium/physiology ; Humans

المؤلفون: Sukumar P; Division of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Leeds, UK, Viswambharan H, Imrie H, Cubbon RM, Yuldasheva N, Gage M, Galloway S, Skromna A, Kandavelu P, Santos CX, Gatenby VK, Smith J, Beech DJ, Wheatcroft SB, Channon KM, Shah AM, Kearney MT

المصدر: Diabetes [Diabetes] 2013 Jun; Vol. 62 (6), pp. 2130-4. Date of Electronic Publication: 2013 Jan 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE

مواضيع طبية MeSH: Endothelial Cells/*drug effects , Insulin Resistance/*physiology , Membrane Glycoproteins/*metabolism , NADPH Oxidases/*metabolism, Acetylcholine/pharmacology ; Animals ; Cells, Cultured ; Chromatography, High Pressure Liquid ; Immunoblotting ; Insulin Resistance/genetics ; Male ; Membrane Glycoproteins/genetics ; Mice ; Mice, Knockout ; NADPH Oxidase 2 ; NADPH Oxidases/genetics ; Polymerase Chain Reaction ; Vasodilator Agents/pharmacology

المؤلفون: Gatenby VK; University of Leeds Multidisciplinary Cardiovascular Research Centre, Leeds, UK., Kearney MT

المصدر: Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2010 Dec; Vol. 14 (12), pp. 1333-42.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101127833 Publication Model: Print Cited Medium: Internet ISSN: 1744-7631 (Electronic) Linking ISSN: 14728222 NLM ISO Abbreviation: Expert Opin Ther Targets Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases*/complications , Cardiovascular Diseases*/drug therapy , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Insulin Resistance* , Obesity*/complications , Obesity*/drug therapy , Obesity*/etiology , Obesity*/metabolism , Vascular Diseases*/complications , Vascular Diseases*/drug therapy, Atherosclerosis/*metabolism , Insulin-Like Growth Factor I/*metabolism, Animals ; Atherosclerosis/complications ; Endothelium, Vascular/physiology ; Humans ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Male ; Molecular Targeted Therapy ; Nitric Oxide/metabolism ; Risk Factors ; Treatment Outcome